PATCH, RESPOND and POLAR studies
PATCH, RESPOND and POLAR studies all continue enrolment of patients.
The NHMRC funded PATCH (Pre-hospital Antifibrinolytics for Traumatic Coagulopathy and Haemorrhage) study, a world first pre-hospital trial in the use of tranexamic acid for patients with acute traumatic coagulopathy, has continued enrolment of patients.
RESPOND is a multicentre RCT to prevent secondary falls in older people presenting to the ED with a fall.
POLAR is an RCT investigating if early therapeutic cooling of patients with severe traumatic brain injury is associated with better outcomes at six months.